MONTRÉAL, April 3, 2019 /CNW
Telbec/ - LGC Capital Ltd. (the "Corporation" or
"LGC") (TSXV: LG) (OTCQB: LGGCF) ("LGC") announces that it
has granted stock options to purchase a total of 8,250,000 common
shares of the Corporation to certain of its officers, employees and
consultants. All of these options are exercisable at a price
of $0.10 per share. The options
have a term of five years and are subject in all respects to the
terms of LGC's stock option plan and the requirements of the TSX
Venture Exchange.
About LGC Capital
LGC is a leading cannabis investment firm with a focus on the
Legal Global Cannabis market. Through its growing portfolio
investment companies, LGC is building a vertically integrated
system of interconnected legal cannabis companies with cultivation,
processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets.
LGC is a Canadian incorporated public company listed on the TSX
Venture Exchange.
Through its partners and assuming pending transactions under
review by the TSXV are approved, LGC presently will have interests
in over 450,000 square feet of planted cannabis in Jamaica, Switzerland, Italy, and Australia. That is expected to increase to
over 2,100,000 square feet by 2021, as its portfolio companies
execute their expansion plans, in addition to the anticipated
licensing of Tricho-Med's operations in Quebec, Canada.
LGC partners currently sell cannabis products in over 1,000
points of sale across Switzerland
and Italy under the ONE Premium
Cannabis and EasyJoint brands as well as medical cannabis oils in
Australia under the Little Green
Pharma brand. LGC's partners' branded products are available in a
variety of formats including dry cannabis flower, tinctures, oils,
seeds, and beverages.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE LGC Capital Ltd
